Cargando…
Prevention of Nausea and Vomiting in Patients Undergoing Oral Anticancer Therapies for Solid Tumors
Chemotherapy-induced nausea and vomiting (CINV) is still a common and debilitating side effect despite recent advances in its prevention and treatment. The intrinsic emetogenicity of chemotherapy agents allowed grouping into four risk groups (high, moderate, low, and minimal risk of emetogenicity)....
Autores principales: | Costa, Ana Lúcia, Abreu, Catarina, Pacheco, Teresa Raquel, Macedo, Daniela, Sousa, Ana Rita, Pulido, Catarina, Quintela, António, Costa, Luís |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4573225/ https://www.ncbi.nlm.nih.gov/pubmed/26421283 http://dx.doi.org/10.1155/2015/309601 |
Ejemplares similares
-
The prognostic role of RANK SNP rs34945627 in breast cancer patients with bone metastases
por: Ferreira, Arlindo, et al.
Publicado: (2016) -
Levels of Circulating Fibroblast Growth Factor 23 (FGF23) and Prognosis in Cancer Patients with Bone Metastases
por: Mansinho, André, et al.
Publicado: (2019) -
Investigation of Nausea and Vomiting in Cancer Patients Undergoing Chemotherapy
por: Lavdaniti, Maria, et al.
Publicado: (2014) -
Nausea, Vomiting, and Dyspepsia Following Solid Organ Abdominal Transplant
por: Jarrett, Simone A, et al.
Publicado: (2022) -
Postoperative nausea and vomiting
por: Moon, Young Eun
Publicado: (2014)